By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Devices for ultrasonic vascular closure and dissection use ultrasonic mechanical vibration to coagulate and dissect blood vessels and other tissue structures. These tools coagulate and dissect tissue by applying pressure along with ultrasonic mechanical vibration.
The majority of these devices produce longitudinal ultrasonic vibration, however some of them can also produce torsional ultrasonic vibration. In actuality, the motion is transmitted as a longitudinal vibratory wave that has numerous nodes and antinodes along the waveguide’s length. Antinodes are locations of highest displacement, while nodes are locations of minimal displacement.
The Canada Ultrasonic dissection devices market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The cordless ultrasonic dissection tool Sonication by Covidien has received FDA 510(k) certification. The gadget can now be used by surgeons for other surgeries like pediatric colectomy, splenectomy, and appendectomy thanks to the approval for expanded lengths.
The groundbreaking cordless technology of the Sonication system from Covidien, a leader in the development of energy-based medical devices, continues to revolutionize minimally invasive surgery.
These new device lengths enable surgeons to use Sonication technology in a more diverse range of surgical procedures, while avoiding the need for cords and separate generators.
The cordless ultrasonic dissection device’s increased mobility makes procedures more efficient and less frustrating to use in sterile environments. Reducing the amount of cords in the operating room (OR) also makes the OR and the patient experience safer.
According to the manufacturer, a surgeon may keep their attention on the operating area rather than the instrument due to the device’s streamlined design. For an unknown sum, Covidien completed the acquisition of Reverse Medical, a US-based privately held medical device company that specializes in treatments for vascular disease. With the acquisition, Covidien will be better able to incorporate Reverse Medical’s operations into its neurovascular product line in the medical devices market.
